ReportsnReports add new market research reprot “Complete 2012 U.S. Cord Blood Banking Industry Report” to its vast collection. 5% Discount Pre-Launch Offer (Expires July 20, 2012)
5% Discount Pre-Launch Offer (Expires July 20, 2012)
If you act now to claim this comprehensive industry report at a 5% discount. But don’t wait, because the report launches Friday, July 20th, 2012 and this offer is only available pre-launch!
As of 2012, the cord blood banking industry is one of the fastest growest industries in the United States. Literally, there were only 23 active cord blood banks as of 2005, and now just 7 years later, there are 485 worldwide. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. Within the U.S., cord blood banks have been multiplying to appear in nearly every state.
This rapid growth represents both an opportunity to profit, as well as swarming competition. It is for this reason that the trends, market intelligence, and little known industry data contained in this report are critical strategies to claim.
* Part 1: U.S. History and Overview – Critical Insights from the Past to the Present
* Part 2: Expansion & Growth – Trailing Twelve Month Analysis and 5-Year Forward Projections
* Part 3: Comprehensive Parent Survey – Continuing to Grow by Listening to Expectant Parents (567 Respondents)
A Roadmap to the Next 5 Years
Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry, as well as revenue growth at existing operations. To guide industry competitors, this report carefully considers the following questions:
* What factors are causing a substantial number of new cord blood banks to open up business?
* What will be the effect of these new entrants to the cord
* How can existing competitors maintain a position of dominance in the industry among this trend?
Deeper analysis also reveals that existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum).
While a similar bimodal distribution existed in the prior 12 month period (trailing 12 to 24 months), the peaks have continued to separate over the past 12 months, with the average flat-growth company staying stagnant and the average revenue growth company increasing its per annum growth rate from 17% per year to 25% per year. This trend indicates an increasing shift in dominance toward fast-growth companies, which begs the questions:
* What are the differences among the cord blood banks that are experiencing flat-line growth, versus those that have substantively building revenue?
* Why are the fast-growth companies continuing to increase their dominance relative to the flat growth companies?
Why Claim the Complete 2012 U.S. Cord Blood Banking Industry Report?
This industry report is a comprehensive road-map for operating a successful cord blood bank, that takes you from the where the industry has been, to where it is, to where is is going (and how to listen strategically to expectant parents to get there fast).
It teaches you – head management of a private cord blood bank – how to strategically position your company to increase market share and attract expectant parents to your services. Rather than focusing on the “medical” and “technical” aspects of cord blood stem cells, the report focuses on the practical and strategic applications necessary to successfully run a private cord blood bank.
While the medical angle is interesting, you already know that part of you business. It would tell you nothing about how to operate a profitable cord blood bank or strategic actions to take to have more expectant parents purchasing cord blood banking services from you, instead of the competition.
Instead, this industry report is focused on your needs and includes content relevant to what you need to know – how to optimally price your services, criteria that make expectant parents likely to purchase private cord blood banking services, and how to grow in a competitive industry.
Like it or not, the cord blood banking industry is getting more and more competitive every day. By doing nothing, clients will likely be won over by better informed competitors.
As of 2012, more and more parents are choosing to publicly bank cord blood, instead of paying for private cord blood banking.
This report is tailored for private cord blood banks, revealing strategy and actionable advice for how to operate profitably and optimally position services to attract parents who now often have the option to publicly bank cord blood.
The Many Benefits to You
BioInformant only produce stem cell industry data. Because stem cells are richly populated in cord blood, we have been tracking the cord blood industry since 2005, when it was an early stage market. Unlike BioInformant, other publishers of cord blood data are broad range publishers without expertise in any specific area – this limits their ability to produce exactly what you need.
We do understand the nuances of your business, because we have been watching your industry since 2005. And, we have never taken our eyes off any of your competition.
7 Years of Extensive Research & Experience
We we started tracking the cord blood banking industry seven years there were only 23 active cord blood banks. There are now 485 worldwide! That is literally a 21-fold increase (2,100%) in the number of companies involved within this industry, over only a seven year period.
Within the United States, there are now 68 active public and private cord blood banks, spread across nearly every U.S. state.
Understanding the drastic increase in the quantity of competition makes it clear why you would benefit from claiming the trends, market intelligence and little known industry data in this report.
Substantiated Future Projections
We track this cord blood banking industry meticulously, year-after-year producing more revealing and accurate data. With great interest, we have annually identified the most successful industry participants and done careful study of the commonalities that exist among this group. We treat these companies as “models” for successful cord blood banking operation.
With equally great interest, we have also annually identified the least successful cord blood companies and done careful study to identify the commonalities that exist among this group. We treat these companies as “warnings” for how to not operate a cord blood bank, unless the goal is to run it into the ground.
In this report, we present our detailed findings for your benefit – we give you the road-map for how to be a fast-growth cord blood bank, so you can avoid the fate of a flat-growth company.
Optimal Foundation For Future Projections
Our historical knowledge of the cord blood industry also means that we have seven years of trailing data on the industry, and are therefore, best optimally positioned to provide you with forward projections for the industry.
While no one can predict the future with 100% certainty (and you should run the other way if they that they can), our foundation of knowledge means that we have the greatest likelihood of accurately predicting future trends and growth within the cord blood industry.
Buy your copy of this report @ http://www.reportsnreports.com/reports/178697-complete-2012-us-cord-blood-banking-industry-report.html
Published: July 2012
Price: Single User License: US$3995 Corporate User License: US$ 5995